G. Arnold

4.7k total citations
76 papers, 2.8k citations indexed

About

G. Arnold is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Arnold has authored 76 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Neurology, 24 papers in Psychiatry and Mental health and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Arnold's work include Neurological disorders and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (27 papers) and Migraine and Headache Studies (19 papers). G. Arnold is often cited by papers focused on Neurological disorders and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (27 papers) and Migraine and Headache Studies (19 papers). G. Arnold collaborates with scholars based in Germany, United States and United Kingdom. G. Arnold's co-authors include Andreas Kupsch, Uwe Reuter, Johannes Schwarz, Thomas Trottenberg, Sigrid Schuh‐Hofer, Thomas Gasser, Axel Lipp, Ulrich Dirnagl, Klaus Tatsch and Heike Israel and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

G. Arnold

76 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Arnold Germany 31 1.6k 720 585 388 300 76 2.8k
G Serratrice France 31 1.5k 1.0× 893 1.2× 557 1.0× 383 1.0× 200 0.7× 234 3.4k
Joong‐Seok Kim South Korea 33 2.1k 1.3× 488 0.7× 414 0.7× 356 0.9× 307 1.0× 196 3.3k
Patrizia Avoni Italy 34 1.2k 0.7× 625 0.9× 597 1.0× 392 1.0× 581 1.9× 86 3.0k
Fukashi Udaka Japan 26 1.2k 0.8× 437 0.6× 334 0.6× 207 0.5× 235 0.8× 104 2.2k
Hiroshi Tsukagoshi Japan 30 953 0.6× 654 0.9× 212 0.4× 474 1.2× 305 1.0× 163 3.2k
Mark Lew United States 29 2.7k 1.7× 1.1k 1.5× 348 0.6× 450 1.2× 156 0.5× 86 3.5k
Roongroj Bhidayasiri Thailand 33 3.0k 1.9× 874 1.2× 550 0.9× 334 0.9× 345 1.1× 222 4.0k
Robert W. Hamill United States 27 805 0.5× 624 0.9× 279 0.5× 440 1.1× 210 0.7× 73 2.5k
Richard B. Dewey United States 29 2.1k 1.3× 925 1.3× 287 0.5× 143 0.4× 239 0.8× 76 2.8k
F. Carella Italy 28 1.4k 0.9× 515 0.7× 376 0.6× 548 1.4× 331 1.1× 78 2.5k

Countries citing papers authored by G. Arnold

Since Specialization
Citations

This map shows the geographic impact of G. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Arnold more than expected).

Fields of papers citing papers by G. Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Arnold. The network helps show where G. Arnold may publish in the future.

Co-authorship network of co-authors of G. Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of G. Arnold. A scholar is included among the top collaborators of G. Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Arnold. G. Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurre, Wiebke, Marta Aguilar Pérez, Sebastian Fischer, et al.. (2014). Solving the Issue of Restenosis After Stenting of Intracranial Stenoses: Experience with Two Thin-Strut Drug-Eluting Stents (DES)—Taxus Element™ and Resolute Integrity™. CardioVascular and Interventional Radiology. 38(3). 583–591. 16 indexed citations
2.
Vajda, Zsolt, Elisabeth Schmid, A. Lindner, et al.. (2011). The Modified Bose Method for the Endovascular Treatment of Intracranial Atherosclerotic Arterial Stenoses Using the Enterprise Stent. Neurosurgery. 70(1). 91–101. 58 indexed citations
3.
Harms, Hendrik, Konstantin Prass, Christian Meisel, et al.. (2008). Preventive Antibacterial Therapy in Acute Ischemic Stroke: A Randomized Controlled Trial. PLoS ONE. 3(5). e2158–e2158. 192 indexed citations
4.
Schuh‐Hofer, Sigrid, Matthias Richter, Lilli Geworski, et al.. (2007). Increased serotonin transporter availability in the brainstem of migraineurs. Journal of Neurology. 254(6). 789–796. 52 indexed citations
5.
Schuh‐Hofer, Sigrid, et al.. (2007). Efficacy of lisinopril in migraine prophylaxis – an open label study. European Journal of Neurology. 14(6). 701–703. 36 indexed citations
6.
Schuh‐Hofer, Sigrid, et al.. (2006). Effects of Parecoxib on Plasma Protein Extravasation and c‐Fos Expression in the Rat. Headache The Journal of Head and Face Pain. 46(2). 276–285. 14 indexed citations
7.
Oertel, Wolfgang H., Erik Ch. Wolters, Cristina Sampaio, et al.. (2005). Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Movement Disorders. 21(3). 343–353. 145 indexed citations
8.
Plotkin, Michail, Holger Amthauer, Stefanie Klaffke, et al.. (2004). Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. Journal of Neural Transmission. 112(5). 677–692. 148 indexed citations
9.
Hälbig, Thomas D., Doreen Gruber, Ute A. Kopp, et al.. (2004). Subthalamic stimulation differentially modulates declarative and nondeclarative memory. Neuroreport. 15(3). 539–543. 38 indexed citations
10.
Lipp, Axel, Jens Tank, Mandy Stoffels, et al.. (2003). Riluzole and blood pressurein multiple system atrophy. Clinical Autonomic Research. 13(4). 271–274. 3 indexed citations
11.
Kupsch, Andreas, Stefanie Klaffke, Wassilios G. Meissner, et al.. (2003). The effects of frequency in pallidal deep brain stimulation for primary dystonia. Journal of Neurology. 250(10). 1201–1205. 60 indexed citations
12.
Obrig, Hellmuth, Heike Israel, Matthias Kohl‐Bareis, et al.. (2002). Habituation of the Visually Evoked Potential and Its Vascular Response: Implications for Neurovascular Coupling in the Healthy Adult. NeuroImage. 17(1). 1–18. 111 indexed citations
13.
14.
Schuh‐Hofer, Sigrid, et al.. (2002). Treatment of acute cluster headache with 20 mg sumatriptan nasal spray – an open pilot study. Journal of Neurology. 249(1). 94–99. 29 indexed citations
15.
Meissner, Wassilios G., Thomas Trottenberg, Stefanie Klaffke, et al.. (2001). Apomorphintherapie versus tiefe HirnstimulationKlinische und ökonomische Aspekte bei Patienten mit fortgeschrittenem Morbus Parkinson. Der Nervenarzt. 72(12). 924–927. 10 indexed citations
16.
Arnold, G. & Andreas Kupsch. (2000). Hemmung der Catechol-O-Methyltransferase. Der Nervenarzt. 71(2). 78–83. 3 indexed citations
17.
Arnold, G., et al.. (1998). Migraine with aura shows gadolinium enhancement which is reversed following prophylactic treatment. Cephalalgia. 18(9). 644–646. 29 indexed citations
18.
Reuter, Uwe, S. Mehraein, G. Arnold, & R. Lehmann. (1997). A "giant" prolactinoma. Journal of Neurology Neurosurgery & Psychiatry. 63(3). 295–295. 5 indexed citations
19.
Arnold, G., Brigitta Bondy, Oliver Bandmann, et al.. (1993). 3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 5(2). 107–116. 7 indexed citations
20.
Schwarz, Johannes, Klaus Tatsch, G. Arnold, et al.. (1992). 123 I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology. 42(3). 556–556. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Serratrice Breakdown of academic impact, for papers by Joong‐Seok Kim Breakdown of academic impact, for papers by Patrizia Avoni Breakdown of academic impact, for papers by Fukashi Udaka Breakdown of academic impact, for papers by Hiroshi Tsukagoshi Breakdown of academic impact, for papers by Mark Lew Breakdown of academic impact, for papers by Roongroj Bhidayasiri Breakdown of academic impact, for papers by Robert W. Hamill Breakdown of academic impact, for papers by Richard B. Dewey Breakdown of academic impact, for papers by F. Carella
Rankless by CCL
2026